Nyrada Inc.

Stocks

Market Closed - Australian S.E. 01:57:32 2026-09-16 EDT			5-day change	1st Jan Change
0.7300 ^AUD	+0.69%		+2.82%	-34.82%

08-20	Nyrada's Xolatryp Drug Candidate Protects Cardiac Function in Preclinical Study; Shares Gain 5%	MT
08-17	Nyrada Inc. Reports Earnings Results for the Full Year Ended June 30, 2026	CI

Published on 02/04/2026 at 10:05 pm EST - Modified on 02/11/2026 at 05:24 pm EST

S&P Capital IQ

Presenter Speech
Dimitri Burshtein (Executives)

Good morning, and welcome to this webinar from Nyrada. Thank you for joining us. My name is Dimitri Burshtein. I'm Nyrada's Director of Investor

This article is reserved for our subscribers.

To unlock the article,
subscribe!

Unlimited browsing across the entire site

Access to all news and data

US, Europe, and Asia portfolios

Ad-free reading

Pro Tools : expert screeners, historical financials, PDF reports, investment themes, and earnings transcripts

08-20	Nyrada's Xolatryp Drug Candidate Protects Cardiac Function in Preclinical Study; Shares Gain 5%	MT
08-17	Nyrada Inc. Reports Earnings Results for the Full Year Ended June 30, 2026	CI
07-26	Nyrada Builds Cash Balance in June Quarter With Receipt of R&D Tax Incentive	MT
07-05	Nyrada Doses First Patient in Phase 2a Trial of Heart Attack Drug Candidate	MT
06-15	Nyrada Says Phase 2a Trial of Heart Attack Drug Candidate on Track for 2027 Completion	MT
06-03	Nyrada Completes Cardioprotection Pilot Study for Lead Drug Candidate	MT
05-20	Nyrada Says 7 Million Unlisted Options Due to Expire in June; Shares Fall 3%	MT
05-19	Nyrada Says Rodent Study Shows Drug Candidate's Anti-Tumor Activity, Shares Up 14%	MT
05-19	Nyrada seeks trading halt	RE
04-21	Nyrada Confirms Activation of First Site in Phase 2a Study of Drug Candidate for Heart Muscle Cell Damage	MT
03-18	Nyrada On Track To Being Site Initiation Visits For Phase IIa Clinical Trial	MT
02-18	Nyrada Inc. Reports Earnings Results for the Half Year Ended December 31, 2025	CI
02-18	Nyrada Discloses Updated Capital Structure	MT
02-17	Nyrada Inc. Announces Board Changes	CI
02-04	Nyrada Inc. - Special Call

Duration

Period

Sector